「The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness」の関連論文
-
頭頸部扁平上皮癌における遺伝子変異と蛋白表現型によるp53機能分類
-
Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer
-
KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma
-
結腸癌術後腹膜播種再発の臨床病理学的特徴とリスク予測に関する検討
-
肺腺癌におけるOvarian cancer immuno-reactive antigen domain containing 2 (OCIAD2) 発現の臨床病理学的意義および機能解析
-
前立腺生検組織におけるDSGb5糖鎖発現の臨床的意義について
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
同時性多発大腸癌の臨床病理・分子学的解析
-
Cholangiographic Tumor Classification for Simple Patient Selection Prior to Hepatopancreatoduodenectomy for Cholangiocarcinoma
-
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue
-
転移・浸潤に関わるタンパク質Rho, ROCKの発現と、同時化学放射線療法後の子宮頸癌の予後との関係について
-
A Clinicopathological Study of Metachronous Anaplastic Carcinoma Transformed from Recurrent Papillary Thyroid Carcinoma
-
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
-
The roles of adipose-tissue and malignant ascites in the development of peritoneal metastasis and the progression of ovarian cancer
-
Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer
-
膵癌における腹腔洗浄液を用いたリキッドバイオプシーの臨床的有用性の検討
-
シングルセルトランスクリプトーム解析を用いた食道扁平上皮癌内の腫瘍浸潤Bリンパ球における化学療法後の機能変化の解明
-
<学会抄録>第70回日本泌尿器科学会中部総会
-
髄膜腫の解剖学的発生部位、病理診断に基づく遺伝子解析研究
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
化学療法後の大腸癌肝転移におけるMRIを用いた腫瘍内脂質検出の臨床的意義
-
癌性腹膜炎を主たる病変とする原発不明癌の一群の予後解析
-
膵神経内分泌腫瘍におけるクロマチンリモデリング因子異常と腫瘍進展・予後との関連
-
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer
-
Occult synchronous liver metastasis from perihilar cholangiocarcinoma
-
Integrated diagnosis based on transcriptome analysis in suspected pediatric sarcomas
-
術前化学療法を施行した食道扁平上皮癌におけるGlucocorticoid(GC)-Glucocorticoid receptor(GR)伝達経路関連因子の臨床病理学的,免疫組織学的検討
-
A multicenter, open‑label, single‑arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
-
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
-
マルチリージョンシークエンスを用いた腫瘍内不均一性と腫瘍進化の過程の解析
-
膵腺癌切除後の肺再発の臨床病理学的特徴とリスク因子
-
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
-
Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection
-
癌患者ゲノミクスデータ解析を基盤とした乳癌幹細胞性維持機構の解明
-
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
食道扁平上皮癌におけるネクロトーシス関連分子の発現と腫瘍浸潤リンパ球に関する検討
-
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
-
Clinical impact of splenic hilar dissection with splenectomy for gastric stump cancer
-
二相撮像FDG-PETを用いた中咽頭癌患者におけるp16発現の関連性および予後予測に関する検討
-
Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
Clinical significance of serglycin expression in human breast cancer patients
-
The Prognostic Significance of Peritumoral Lymphocytes’ Band-like Structure in Type II Endometrial Cancer
-
皮膚原発神経内分泌腫瘍におけるRB1遺伝子のターゲットシーケンスを含む臨床病理学的検討
-
Runx3の下流遺伝子群の解析による悪性黒色腫に対する新規治療標的の創出
-
Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma
-
原発性膠芽腫におけるTERTプロモーター領域遺伝子変異の臨床的・病理学的意義
-
Micro RNA-10a in pancreatic juice revealed to be a malignant marker for intraductal papillary mucinous neoplasms
-
リスク因子別にみた表在型食道扁平上皮癌のゲノム変化の特徴